4.7 Article

The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease

期刊

JOURNAL OF NEUROINFLAMMATION
卷 15, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s12974-018-1309-z

关键词

Tau; Microglia; Alzheimer's disease

资金

  1. Massachusetts Center for Alzheimer's Therapeutic Studies (MassCATS)
  2. Commonwealth of Massachusetts supporting precompetitive Alzheimer's disease research
  3. National Institutes of Health [P50 AG005134]
  4. JPB Foundation

向作者/读者索取更多资源

Background: Misfolding of microtubule-associated protein tau (MAPT) within neurons into neurofibrillary tangles is an important pathological feature of Alzheimer's disease (AD). Tau pathology correlates with cognitive decline in AD and follows a stereotypical anatomical course; several recent studies indicate that tau pathology spreads inter-neuronally via misfolded tau seeds. Previous research has focused on neurons as the source of these tau seeds. However, recent studies as well as the data contained herein suggest that microglia, the resident immune cells of the central nervous system, play a direct role in the spread of tau pathology. Methods: Primary adult microglia were isolated from human AD cases and the rTg4510 tauopathy mouse model and used for analysis of gene expression, tau protein by Simoa technology, and quantification of tau seeding using a highly sensitive fluorescence resonance energy transfer (FRET) biosensing cell line for tau seeding and aggregation. Results: Here, we show that microglia isolated from both human tauopathy and AD cases and the rTg4510 tauopathy mouse model stably contain tau seeds, despite not synthesizing any tau. Microglia releases these tau seeds in vitro into their conditioned media (CM). This suggests that microglia have taken up tau but are incapable of entirely neutralizing its seeding activity. Indeed, when in vitro microglia are given media containing tau seeds, they reduce (but do not eliminate) tau seeding. When microglia are treated with inflammagens such as lipopolysaccharide (LPS), interleukin-1 beta (IL1 beta), tumor necrosis factor alpha (TNF alpha), or amyloid-beta, their ability to reduce tau seeding is unchanged and these factors do not induce seeding activity on their own. Conclusions: Overall, these data suggest that microglia have a complex role: they are capable of taking up and breaking down seed competent tau, but do so inefficiently and could therefore potentially play a role in the spread of tau pathology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain

Sarah L. DeVos, Bianca T. Corjuc, Derek H. Oakley, Chloe K. Nobuhara, Riley N. Bannon, Alison Chase, Caitlin Commins, Jose A. Gonzalez, Patrick M. Dooley, Matthew P. Frosch, Bradley T. Hyman

FRONTIERS IN NEUROSCIENCE (2018)

Article Oncology

Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study

K. Ina Ly, Derek H. Oakley, Alexander B. Pine, Matthew P. Frosch, Sy Han Chiou, Rebecca A. Betensky, Stuart R. Pomerantz, Fred H. Hochberg, Tracy T. Batchelor, Daniel P. Cahill, Jorg Dietrich

ONCOLOGIST (2019)

Article Medicine, General & Internal

Case 23-2019: A 52-Year-Old Man with Fever, Cough, and Hypoxemia

Charles C. Hardin, Rajeev Malhotra, Milena Petranovic, Sheila Klassen, Nino Mihatov, Derek H. Oakley

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Clinical Neurology

Spinal cord α-synuclein deposition associated with myoclonus in patients with MSA-C

Jaeho Hwang, Anna M. Bank, Farzad Mortazavi, Derek H. Oakley, Matthew P. Frosch, Jeremy D. Schmahmann

NEUROLOGY (2019)

Review Neurosciences

Targeting microglia L-type voltage-dependent calcium channels for the treatment of central nervous system disorders

Sarah C. Hopp

Summary: This review explores the potential of L-VDCCs as a target for treating CNS disorders, with a focus on their role in microglia. Microglia play a crucial role in the inflammatory response in various CNS diseases, making the calcium signaling pathway a valuable target for manipulation.

JOURNAL OF NEUROSCIENCE RESEARCH (2021)

Article Clinical Neurology

The Alzheimer Disease-Causing Presenilin-1 L435F Mutation Causes Increased Production of Soluble Aβ43 Species in Patient-Derived iPSC-Neurons, Closely Mimicking Matched Patient Brain Tissue

Derek H. Oakley, Mirra Chung, Naomi Klickstein, Caitlin Commins, Bradley T. Hyman, Matthew P. Frosch

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)

Article Biochemistry & Molecular Biology

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease

Simon Dujardin, Caitlin Commins, Aurelien Lathuiliere, Pieter Beerepoot, Analiese R. Fernandes, Tarun Kamath, Mark B. De Los Santos, Naomi Klickstein, Diana L. Corjuc, Bianca T. Corjuc, Patrick M. Dooley, Arthur Viode, Derek H. Oakley, Benjamin D. Moore, Kristina Mullin, Dinorah Jean-Gilles, Ryan Clark, Kevin Atchison, Renee Moore, Lori B. Chibnik, Rudolph E. Tanzi, Matthew P. Frosch, Alberto Serrano-Pozo, Fiona Elwood, Judith A. Steen, Matthew E. Kennedy, Bradley T. Hyman

NATURE MEDICINE (2020)

Article Medicine, General & Internal

SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS

Christian Mueller, James D. Berry, Diane M. McKenna-Yasek, Gwladys Gernoux, Margaret A. Owegi, Lindsay M. Pothier, Catherine L. Douthwright, Dario Gelevski, Sarah D. Luppino, Meghan Blackwood, Nicholas S. Wightman, Derek H. Oakley, Matthew P. Frosch, Terrence R. Flotte, Merit E. Cudkowicz, Robert H. Brown

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Neurosciences

Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons

Derek H. Oakley, Naomi Klickstein, Caitlin Commins, Mirra Chung, Simon Dujardin, Rachel E. Bennett, Bradley T. Hyman, Matthew P. Frosch

Summary: This study established an accelerated human neuronal model incorporating soluble tau species and tau aggregation, and showed that uptake of exogenous tau seeds increases the risk of neuronal death. Specific morphologic strains of Tau aggregation were identified to be associated with differing levels of neurotoxicity. Additionally, iPSC neurons expressing the PSEN1 L435F mutation exhibited accelerated Tau aggregation kinetics and a bias in tau strain propagation.

JOURNAL OF NEUROSCIENCE (2021)

Article Neurosciences

L-type calcium channel antagonist isradipine age-dependently decreases plaque associated dystrophic neurites in 5XFAD mouse model

Jessica L. Wickline, Sabrina Smith, Riley Shin, Kristian Odfalk, Jesse Sanchez, Martin Javors, Brett Ginsburg, Sarah C. Hopp

Summary: Epidemiological studies suggest that L-type calcium channel antagonists may reduce the incidence of age-associated neurodegenerative diseases, including Alzheimer's disease. However, the protective mechanism of LTCC antagonists is unknown.

NEUROPHARMACOLOGY (2023)

Article Neurosciences

Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease

Kristian F. Odfalk, Jessica L. Wickline, Sabrina Smith, Radek Dobrowolski, Sarah C. Hopp

Summary: Dysfunction of the endosomal-lysosomal network is a notable feature of Alzheimer's disease, and TMEM55B may play a role in reducing this dysfunction.

HIPPOCAMPUS (2023)

Article Clinical Neurology

Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer's cases

Tarun Kamath, Naomi Klickstein, Caitlin Commins, Analiese R. Fernandes, Derek H. Oakley, Matthew P. Frosch, Bradley T. Hyman, Simon Dujardin

Summary: The accumulation of tau aggregates in tauopathies display "prion-like" behavior, with differences in structures among different conditions. Recent studies have shown biochemical and bioactive differences in tau species among individuals with sporadic Alzheimer's disease. Live-cell imaging revealed a consistent aggregation pattern with distinct parameters, including lag phase and growth phase, dependent on seeding-competent tau concentration. The kinetics of aggregation may reflect underlying structural differences in tau aggregates, confirming heterogeneity in tau proteopathic seeds among Alzheimer's disease patients.

BRAIN COMMUNICATIONS (2021)

Meeting Abstract Clinical Neurology

Patient-derived induced pluripotent stem cells from brain donors for the study of Alzheimer's disease and other neurodegenerative disorders

Derek Oakley, Naomi Klickstein, Bradley Hyman, Matthew Frosch

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

暂无数据